In vitro evidence for homologous recombinational repair in resistance to melphalan

Z M Wang1, Z P Chen, Z Y Xu

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada.

Abstract

Insights

Melphalan resistance in epithelial tumors is linked to homologous recombinational repair. Higher Xrcc3 protein levels and more Rad51 foci indicate increased melphalan resistance, suggesting this repair pathway is key.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • DNA Repair

Background:

  • Nitrogen mustards like melphalan generate DNA interstrand cross-links, crucial for their antitumor activity.
  • Cell lines with faulty recombinational repair are sensitive to nitrogen mustards.
  • Melphalan resistance may involve accelerated DNA repair via homologous recombination (Rad51-related proteins) or nonhomologous endjoining (DNA-PK, Ku proteins).

Purpose of the Study:

  • To investigate the role of DNA repair mechanisms in melphalan resistance.
  • To determine if homologous recombination or nonhomologous endjoining pathways contribute to resistance in epithelial tumor cell lines.

Main Methods:

  • Assessed melphalan cytotoxicity using the sulforhodamine assay in 14 epithelial tumor cell lines.
  • Investigated homologous recombinational repair by measuring Rad51, Rad52, and Xrcc3 protein levels and melphalan-induced Rad51 foci.
  • Examined nonhomologous endjoining by quantifying Ku70, Ku86 protein levels, and DNA-PK activity.
  • Used linear regression to correlate protein levels, DNA-PK activity, and Rad51 foci with melphalan cytotoxicity.

Main Results:

  • Melphalan resistance showed a significant correlation with Xrcc3 protein levels (r =.587; P =.027).
  • A strong correlation was observed between melphalan resistance and the density of melphalan-induced Rad51 foci (r =.848; P =.008).
  • No significant correlation was found between melphalan resistance and Rad51, Rad52, Ku protein levels, or DNA-PK activity.

Conclusions:

  • The findings suggest that homologous recombinational repair plays a role in melphalan resistance.
  • Elevated Xrcc3 protein levels and increased Rad51 foci density are indicators of melphalan resistance in epithelial tumor cells.
  • This highlights the importance of the homologous recombinational repair pathway in the cellular response to melphalan treatment.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...